Case Study: Reaching the Unreachable in Rare Disease

Learn how OptimizeRx’s patented, privacy-safe AI technology increased audience quality by 75%

Read the Story!

Despite having the only FDA-approved treatment for a rare disease, an in-line pharma brand struggled to reach and engage their target population. The likely cause? An overreliance on demographic modeling, complex diagnostic criteria, frequent misdiagnoses, and consumer targeting limitations. 

By evolving their DTC marketing with OptimizeRx’s patented, AI-driven technology, the brand saw: 

  • 75% increase in Audience Quality (AQ) 
  • 92% increase in website engagement 
  • 9,700 diagnosed patients reached 
  • 2x more new diagnoses  

Learn more about the predictive, privacy-safe approach at the heart of this brand’s success. Download the full case study. 

25Q12230-DAAPDTC-LPImage